These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 753371)

  • 21. Crystallization of isoelectrically homogeneous cholera toxin.
    Spangler BD; Westbrook EM
    Biochemistry; 1989 Feb; 28(3):1333-40. PubMed ID: 2713368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of cholera toxin subunit A with cultured adrenal cells.
    Knoop FC
    Can J Microbiol; 1978 Aug; 24(8):915-21. PubMed ID: 688100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of a hormone-like factor which inhibits cholera secretion.
    Lönnroth I; Lange S
    FEBS Lett; 1984 Nov; 177(1):104-8. PubMed ID: 6500048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difference in resistance of subunits A and B of Vibrio cholerae toxin (choleragen) to treatment with pronase.
    Neri P; Antoni G; Tarli P
    Experientia; 1978 Oct; 34(10):1293-4. PubMed ID: 738397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemistry of Vibrio cholerae Virulence I. Purification and Biochemical Properties of PF/Cholera Enterotoxin.
    Richardson SH; Evans DG; Feeley JC
    Infect Immun; 1970 Jun; 1(6):546-54. PubMed ID: 16557774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analytical determination and control of the decomposition of macromolecular polypeptides].
    Burger K; Pékli M
    Acta Pharm Hung; 1979 Mar; 49(2):83-7. PubMed ID: 443056
    [No Abstract]   [Full Text] [Related]  

  • 27. Fractionation of biologically active and inactive populations of human rhinovirus type 2.
    Korant BD; Lonberg-Holm K; Yin FH; Noble-Harvey J
    Virology; 1975 Feb; 63(2):384-94. PubMed ID: 163526
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular properties of cholera enteroxin.
    Okajima Y; Shimamura T; Ozawa A; Sasaki S
    Tokai J Exp Clin Med; 1981 Apr; 6(2):193-201. PubMed ID: 7303003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a CHO cell-elongating factor produced by Vibrio cholerae O1.
    McCardell BA; Kothary MH; Hall RH; Sathyamoorthy V
    Microb Pathog; 2000 Jul; 29(1):1-8. PubMed ID: 10873485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane-bound enterotoxin of Vibrio cholerae.
    Fernandes PB; Bayer ME
    J Gen Microbiol; 1977 Dec; 103(2):381-7. PubMed ID: 599329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
    Zarnegar R; Michalopoulos G
    Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The aggregational status of cholera enterotoxin fragment A following biochemical fractionation.
    Knoop FC
    Biochem Exp Biol; 1978; 14(2):125-31. PubMed ID: 753371
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.